International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel

Author(s): Allen Loyd V Jr

Issue: May/Jun 2011 - Volume 15, Number 3
View All Articles in Issue

Page(s): 242

Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, amitriptyline, dextromethorphan hydrobromide, tramadol hydrochloride, topical preparation, neuropathic pain, neuropathy, pain relief, analgesic, analgesia, drug combination

Related Categories: FORMULATIONS, PAIN MANAGEMENT, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel Allen Loyd V Jr	May/Jun 2011 Pg. 242
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL Allen Loyd V Jr	Mar/Apr 2024 Pg. 130
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel Allen Loyd V Jr	Nov/Dec 2008 Pg. 541
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 512
Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh	Jan/Feb 2022 Pg. 65-71
Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules Allen Loyd V Jr	May/Jun 2009 Pg. 249
Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel Allen Loyd V Jr	Jan/Feb 2009 Pg. 66
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Allen Loyd V Jr	Mar/Apr 2011 Pg. 157
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Allen Loyd V Jr	Mar/Apr 2024 Pg. 131
Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules Allen Loyd V Jr	May/Jun 2009 Pg. 246
Dextromethorphan Hydrobromide 15-mg Oral Film Strip Allen Loyd V Jr	Mar/Apr 2011 Pg. 159
Dextromethorphan Hydrobromide 30-mg Troches Allen Loyd V Jr	Jan/Feb 2009 Pg. 67
Dextromethorphan Hydrobromide and Opioid Tolerance: A Compounding Opportunity for Pharmacists with Chronic Pain Patients Kane Dana Lynn, Glasnapp Andrew	Mar/Apr 1998 Pg. 118-119
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Mar/Apr 2024 Pg. 100-109
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Update on Managing Neuropathic Pain McNulty Jack P, Muller George	May/Jun 2009 Pg. 182-190
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel Allen Loyd V Jr	May/Jun 2009 Pg. 245
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott	May/Jun 2013 Pg. 247-253
Return to Top